Click any annotated section or its icon to see analysis.
Section 1
1. Extending eligibility for certain payment increases for biosimilar biological products under the Medicare program Section 1847A(b)(8)(B)(ii)(II) of the Social Security Act (42 U.S.C. 1395w–3a(b)(8)(B)(ii)(II)) is amended by striking 2027 and inserting 2032.